Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma

Wei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jié He(Chinese Academy of Medical Sciences & Peking Union Medical College), Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenlin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengwei Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Guochao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhen Wang(Xi'an Jiaotong University), Renda Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Immunology
May 12, 2021
10.3389/fimmu.2021.669750
Cited by 84

Related Papers

TGF-β signaling in health, disease and therapeutics
|Signal Transduction and Targeted Therapy|2024|917
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding
|Nature Communications|2021|193
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192